NOV Inc. (NOV)
Reports for NOV Inc.
NOV Inc.
NOV
Industries
105
105001
Analysis
No analyses available for NOV Inc. yet.
Latest News about NOV Inc.
NASDAQ
INOVIO Announces Promising Interim Results From Phase 1 Proof-of-Concept Trial Of DMAbs For COVID-19
1741914708
| NASDAQ
AI-Powered trading insights: join our email list
Trusted by traders and financial professionals around the globe.
Real-Time Market Analysis
Get instant insights on market trends, news impact, and trading opportunities.
